LAVONIA WOMACK: Open Payments
NPI 1528039252 · LINCOLNTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 20 payments from 6 companies in 2025. Trend: 2023 $308 · 2024 $165 · 2025 $636
Food & beverage: $525Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $205 |
| ABBVIE INC. | 9 | $157 |
| Madrigal Pharmaceuticals | 3 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $113 |
| GENZYME CORPORATION | 1 | $14 |
| Janssen Pharmaceuticals, Inc | 1 | $10 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, SKYRIZI, LINZESS, CREON, DUPIXENT, RINVOQ.
Industry payments across NC — which companies pay providers there.
